Synergism of combined lithium-neuroleptic therapy: a double-blind, placebo-controlled case study
- 1 January 1981
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 138 (1) , 81-83
- https://doi.org/10.1176/ajp.138.1.81
Abstract
A longitudinal, placebo controlled study is described of the response to drug treatment of a 62 yr old schizoaffective patient hospitalized for 40 yr. While neither L nor a neuroleptic drug (acetophenazine) alone was effective, both drugs administered simultaneously led to the gradual extinction of a pronounced behavioral cycle and the disappearance of manifest psychosis. A synergistic interaction between the 2 drugs is suggested. The need for sustained trials of the combination in patients with similar behavioral cycles is stressed.This publication has 7 references indexed in Scilit:
- Effect of neuroleptic drugs on lithium uptake by the human erythrocyteClinical Pharmacology & Therapeutics, 1979
- Lithium in Chronic SchizophreniaAmerican Journal of Psychiatry, 1979
- Combination of Lithium Carbonate and Haloperidol in Schizo-affective DisorderArchives of General Psychiatry, 1979
- Morbidity Suppressive Effect of Lithium Carbonate in Cycloid PsychosisArchives of General Psychiatry, 1978
- A Comparison of Lithium Carbonate and Chlorpromazine in the Treatment of Excited Schizo-AffectivesArchives of General Psychiatry, 1972
- A Controlled Study of Lithium vs. Chlorpromazine in Acute SchizophrenicsThe British Journal of Psychiatry, 1971
- Comparative Effects of Lithium and Chlorpromazine in the Treatment of Acute Manic StatesThe British Journal of Psychiatry, 1971